Prognostic Factors on Malignant Pleural Effusion
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03276715|
Recruitment Status : Recruiting
First Posted : September 8, 2017
Last Update Posted : September 11, 2017
Malignant pleural effusion can occur in up to half of the patients with metastatic disease. It can cause shortness of breath to patients and so far there is no protocol on its management.
The study is looking at patients with malignant pleural effusion and aims to identify its prognostic factors.
Pleural fluid and blood analysis will be performed as in the standard of care and results will be collected at the start of diagnosis. This will not affect subsequent management plan. Patients' disease course will be followed up and progress data will be collected. Data will then be analysed to identify relevant prognostic factors.
|Condition or disease|
|Pleural Effusion, Malignant Lung Cancer|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||40 participants|
|Target Follow-Up Duration:||3 Years|
|Official Title:||A Cohort Study of Prognostic Factors in Lung Cancer Patients With Malignant Pleural Effusion (MPE).|
|Actual Study Start Date :||June 1, 2016|
|Estimated Primary Completion Date :||June 1, 2019|
|Estimated Study Completion Date :||December 31, 2019|
- Further pleural intervention [ Time Frame: 3 years ]Rate of fluid recurrence requiring invasive pleural interventions
- Survival [ Time Frame: 3 years ]survival of lung cancer patient with malignant pleural effusion
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03276715
|Contact: Ka Yan Chiang, MBBS (HK)||email@example.com|
|Contact: Mei Sze Macy Lui, MBBS (HK), FHKCP, FHKAMfirstname.lastname@example.org|
|Queen Mary Hospital||Recruiting|
|Hong Kong, Hong Kong|
|Contact: Ka Yan Chiang, MBBS(HK) 25182111 email@example.com|
|Sub-Investigator: Macy Mei Sze Lui, MBBS(HK),FHKCP,FHKAM|
|Sub-Investigator: Mary Sau Man Ip, MBBS(HK),FHKCP,FHKAM, MD|
|Principal Investigator:||Ka Yan Chiang, MBBS(HK)||Queen Mary Hospital, Hong Kong|